Header Logo

GREGORY N FULLER

TitleProfessor
InstitutionMD Anderson
DepartmentPathology
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Li H, Hu X, Ning MS, Fuller GN, Stewart JM, Gilliam JC, Wu J, Le X, Vaporciyan AA, Lee JJ, Gibbons DL, Heymach JV, Futreal A, Zhang J. Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features. Front Oncol. 2024; 14:1324057. PMID: 38590653; PMCID: PMC10999639.
      Citations:    
    2. Humphries W, Wang Y, Qiao W, Reina-Ortiz C, Abou-Ghazal MK, Crutcher LM, Wei J, Kong LY, Sawaya R, Rao G, Weinberg J, Prabhu SS, Fuller GN, Heimberger AB. Correction: Detecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients. J Transl Med. 2024 Mar 21; 22(1):296. PMID: 38515188; PMCID: PMC10958894.
      Citations:    Fields:    
    3. Kumar VA, Perez A, Young AL, Jones J, O'Brien BJ, Lang FF, Huse JT, Fuller GN. Collision tumor: Multinodular and vacuolating neuronal tumor with isocitrate dehydrogenase-mutant diffuse astrocytoma. Neuropathology. 2024 Feb 27. PMID: 38414131.
      Citations:    Fields:    
    4. Zheng L, Luthra R, Alvarez HA, San Lucas FA, Duose DY, Wistuba II, Fuller GN, Ballester LY, Roy-Chowdhuri S, Sweeney KJ, Rashid A, Yang RK, Chen W, Liu A, Wu Y, Albarracin C, Patel KP, Routbort MJ, Sahin AA, Ding Q, Chen H. Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors. Cancers (Basel). 2023 Dec 19; 16(1). PMID: 38201434; PMCID: PMC10778229.
      Citations: 1     
    5. Haider AS, McCutcheon IE, Ene CI, Fuller GN, Schomer DF, Gule-Monroe M, DeMonte F, Ferguson SD, Lang FF, Prabhu SS, Raza SM, Suki D, Weinberg JS, Sawaya R. Subependymomas of the fourth ventricle: To operate or not to operate? J Clin Neurosci. 2023 Dec; 118:147-152. PMID: 37944358.
      Citations:    Fields:    Translation:Humans
    6. Dagher SA, Lochner RH, Ozkara BB, Schomer DF, Wintermark M, Fuller GN, Ucisik FE. The T2-FLAIR mismatch sign in oncologic neuroradiology: History, current use, emerging data, and future directions. Neuroradiol J. 2023 Nov 04; 19714009231212375. PMID: 37924213.
      Citations:    Fields:    
    7. Singh SK, Wang Y, Habib A, Priyadarshini M, Kodavali CV, Chen A, Ma W, Wang J, Hameed NUF, Hu B, Fuller GN, Kulich SM, Amankulor N, Colen RR, Edwards LA, Zinn PO. TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype in vitro. Front Oncol. 2023; 13:1279806. PMID: 37881491; PMCID: PMC10597663.
      Citations:    
    8. Shehabeldin A, Rohra P, Sellen LD, Zhao J, Alqaidy D, Aramin H, Hameed N, Perez YE, Lai Z, Tong YT, Milton DR, Edgerton ME, Fuller G, Hansel D, Prieto VG, Ballester LY, Aung PP. Utility of Whole Slide Imaging for Intraoperative Consultation: Experience of a Large Academic Center. Arch Pathol Lab Med. 2023 Sep 26. PMID: 37756559.
      Citations:    Fields:    
    9. Rasband JM, Alfattal R, Patel AJ, Fuller GN, Perry A, Lu HC. Cavernous sinus hemangioma: Histopathological spectrum of 8 cases. J Neuropathol Exp Neurol. 2023 09 20; 82(10):884-886. PMID: 37487571.
      Citations: 1     Fields:    Translation:Humans
    10. Farhat M, Fuller GN, Wintermark M, Chung C, Kumar VA, Chen M. Multifocal and multicentric glioblastoma: Imaging signature, molecular characterization, patterns of spread, and treatment. Neuroradiol J. 2023 Aug 10; 19714009231193162. PMID: 37559514.
      Citations: 2     Fields:    
    11. Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK. Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad032. PMID: 37114244; PMCID: PMC10129387.
      Citations:    
    12. Gregory TA, Williford GL, Maronge JM, Alfaro K, Fuller GN, de Groot J, Puduvalli VK, Ballester LY, Majd NK. An expedited strategy for accurate and timely integrated molecular diagnosis of?gliomas. Neuro Oncol. 2023 04 06; 25(4):808-809. PMID: 36723868; PMCID: PMC10076931.
      Citations:    Fields:    Translation:Humans
    13. Haider AS, Ene CI, Palmisciano P, Haider M, Rao G, Ballester LY, Fuller GN. Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report. Front Oncol. 2023; 13:1071792. PMID: 37077830; PMCID: PMC10108912.
      Citations:    
    14. Ozkizilkaya HI, Johnson JM, O'Brien BJ, McCutcheon IE, Prabhu SS, Ghia AJ, Fuller GN, Huse JT, Ballester LY. Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad026. PMID: 37051329; PMCID: PMC10084497.
      Citations:    
    15. Agnihotri S, Golbourn B, Huang X, Remke M, Younger S, Cairns RA, Chalil A, Smith CA, Krumholtz SL, Mackenzie D, Rakopoulos P, Ramaswamy V, Taccone MS, Mischel PS, Fuller GN, Hawkins C, Stanford W, Taylor MD, Zadeh G, Rutka JT. Correction: PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. Cancer Res. 2022 Dec 16; 82(24):4695. PMID: 36524349.
      Citations:    Fields:    
    16. Lu L, Marisetty A, Liu B, Kamal MM, Gumin J, Veo B, Cai Y, Kassem DH, Weng C, Maynard ME, Hood KN, Fuller GN, Pan ZZ, Cykowski MD, Dash PK, Majumder S. Author Correction: REST overexpression in mice causes deficits in spontaneous locomotion. Sci Rep. 2022 Dec 16; 12(1):21759. PMID: 36526687.
      Citations:    Fields:    
    17. Pokhylevych H, Khose S, Amer A, Alhasan H, Kaya D, Johnson R, Fuller G, Gruschkus SK, Zaky W, Weinberg JS, Johnson JM. Retrospective Analysis of Imaging Characteristics of Tectal Gliomas. J Comput Assist Tomogr. 2022 Nov 27. PMID: 36598462.
      Citations:    Fields:    
    18. Khan AB, Lee S, Harmanci AS, Patel R, Latha K, Yang Y, Marisetty A, Lee HK, Heimberger AB, Fuller GN, Deneen B, Rao G. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma. Int J Cancer. 2023 02 15; 152(4):713-724. PMID: 36250346; PMCID: PMC10071545.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    19. Amit M, Xie T, Gleber-Netto FO, Hunt PJ, Mehta GU, Bell D, Silverman DA, Yaman I, Ye Y, Burks JK, Fuller GN, Gidley PW, Nader ME, Raza SM, DeMonte F. Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. J Exp Clin Cancer Res. 2022 Oct 04; 41(1):292. PMID: 36195959; PMCID: PMC9531347.
      Citations: 1     Fields:    Translation:Humans
    20. Pokhylevych H, Khose S, Gule-Monroe MK, Chen MM, Fuller G, Gruschkus SK, Sadighi Z, Zaky W, Sandberg DI, McGovern SL, Johnson JM. Contrast Enhancement Patterns in Pediatric Glioblastomas. J Comput Assist Tomogr. 2022 Sep 07. PMID: 36112052.
      Citations:    
    21. Upadhyay R, Khose S, Pokhylevych H, Paulino AC, McAleer MF, Ghia A, Li J, Yeboa DN, Loghin M, Harrison R, O'Brien B, Kamiya-Matsuoka C, De Groot J, Puduvalli VK, Tatsui C, Alvarez-Breckenridge C, Prabhu S, Rhines L, Zaky W, Lin F, Weinberg JS, Fuller G, Sandberg DI, Johnson JM, McGovern SL. Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac129. PMID: 36128585; PMCID: PMC9476222.
      Citations:    
    22. Groot J, Ott M, Wei J, Kassab C, Fang D, O'Brien B, Weathers SP, Matsouka CK, Majd NK, Harrison RA, Fuller GN, Huse JT, Long JP, Sawaya R, Rao G, MacDonald TJ, Priebe W, Najem H, DeCuypere M, Heimberger AB. A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. CNS Oncol. 2022 06 01; 11(2):CNS87. PMID: 35575067; PMCID: PMC9134932.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    23. Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, Krishnan SN, Varn FS, Gupta P, Ferguson SD, Huse JT, Fuller GN, Long JP, Winkowski DE, Freiberg BA, James CD, Platanias LC, Lesniak MS, Burks JK, Heimberger AB, Arrieta VA. Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. JCI Insight. 2022 05 09; 7(9). PMID: 35316217; PMCID: PMC9090258.
      Citations: 1     Fields:    Translation:HumansCells
    24. Haider AS, El Ahmadieh TY, Haider M, Hatanpaa KJ, Pinho MC, Mickey BE, Sawaya R, Fuller GN, Schomer DF, Gule-Monroe M. Imaging characteristics of 4th ventricle subependymoma. Neuroradiology. 2022 Sep; 64(9):1795-1800. PMID: 35426054; PMCID: PMC9365749.
      Citations:    Fields:    
    25. Gopakumar S, McDonald MF, Sharma H, Tatsui CE, Fuller GN, Rao G. Recurrent HGNET-MN1 altered (astroblastoma MN1-altered) of the foramen magnum: Case report and molecular classification. Surg Neurol Int. 2022; 13:139. PMID: 35509530; PMCID: PMC9062895.
      Citations:    
    26. Amer A, Khose S, Alhasan H, Pokhylevych H, Fuller G, Chasen N, de Groot J, Johnson JM. Clinical and survival characteristics of primary and secondary gliosarcoma patients. Clin Neurol Neurosurg. 2022 03; 214:107146. PMID: 35101778.
      Citations:    Fields:    Translation:Humans
    27. Shepard MJ, Haider AS, Prabhu SS, Sawaya R, DeMonte F, McCutcheon IE, Weinberg JS, Ferguson SD, Suki D, Fuller GN, Lang FF. Long term outcomes following surgery for pineal region tumors. J Neurooncol. 2022 Feb; 156(3):491-498. PMID: 35083579.
      Citations: 1     Fields:    Translation:Humans
    28. Wolff JE, Van Gool SW, Kutluk T, Diez B, Kebudi R, Timmermann B, Garami M, Sterba J, Fuller GN, Bison B, Kordes UR. Final results of the Choroid Plexus Tumor study CPT-SIOP-2000. J Neurooncol. 2022 Feb; 156(3):599-613. PMID: 34997889; PMCID: PMC8860833.
      Citations: 1     Fields:    Translation:Humans
    29. Jaroudi S, Faiz SA, Fuller G, Rubio D. Spinal cord compression revealing metastatic cancer. Am J Med Sci. 2022 06; 363(6):e56-e57. PMID: 34752739.
      Citations:    Fields:    Translation:Humans
    30. Melendez-Zaidi AE, Ou A, Fuller GN. Carcinomatosis Encephalitis Secondary to Neuroendocrine Transformation of Prostate Cancer. JAMA Neurol. 2021 11 01; 78(11):1391-1392. PMID: 34570201.
      Citations:    Fields:    Translation:Humans
    31. Salzillo TC, Mawoneke V, Weygand J, Shetty A, Gumin J, Zacharias NM, Gammon ST, Piwnica-Worms D, Fuller GN, Logothetis CJ, Lang FF, Bhattacharya PK. Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. Cells. 2021 10 01; 10(10). PMID: 34685601; PMCID: PMC8534002.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    32. Harish Bindiganavile S, Fuller GN, Bhat N, Lee AG, Wheelock-Gutierrez L, Ch?vez-Barrios P. Juxtaposed Homonymous Hemianopsia Due to Neurotuberculosis. J Neuroophthalmol. 2021 Sep 01; 41(3):e303-e306. PMID: 32956231.
      Citations:    Fields:    Translation:Humans
    33. Majd NK, Mastall M, Lin H, Dibaj SS, Hess KR, Yuan Y, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harriso RA, De Groo JF, Puduvalli VK, Penas-Prado M, Garcia MM. Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab079. PMID: 34377987; PMCID: PMC8350154.
      Citations: 1     
    34. Aaroe AE, Glitza Oliva IC, Al-Zubidi N, Nader ME, Kaya D, Ferguson SD, Wang C, Fuller G, Harrison RA. Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. Neurology. 2021 08 03; 97(5):248-250. PMID: 33931525.
      Citations:    Fields:    Translation:HumansCells
    35. Ferguson SD, Hodges TR, Majd NK, Alfaro-Munoz K, Al-Holou WN, Suki D, de Groot JF, Fuller GN, Xue L, Li M, Jacobs C, Rao G, Colen RR, Xiu J, Verhaak R, Spetzler D, Khasraw M, Sawaya R, Long JP, Heimberger AB. A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdaa146. PMID: 33426529; PMCID: PMC7780842.
      Citations: 1     
    36. Bell D, Bell A, Ferrarotto R, Glisson B, Takahashi Y, Fuller G, Weber R, Hanna E. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Ann Diagn Pathol. 2020 Dec; 49:151622. PMID: 32927372.
      Citations:    Fields:    Translation:HumansCells
    37. Ott M, Tomaszowski KH, Marisetty A, Kong LY, Wei J, Duna M, Blumberg K, Ji X, Jacobs C, Fuller GN, Langford LA, Huse JT, Long JP, Hu J, Li S, Weinberg JS, Prabhu SS, Sawaya R, Ferguson S, Rao G, Lang FF, Curran MA, Heimberger AB. Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. JCI Insight. 2020 09 03; 5(17). PMID: 32721947; PMCID: PMC7526457.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    38. Mullarkey MP, Nehme G, Mohiuddin S, Ballester LY, Bhattacharjee MB, Trivedi D, Shah MN, Fuller GN, Zaky W, Sandberg DI. Posttreatment Maturation of Medulloblastoma into Gangliocytoma: Report of 2 Cases. Pediatr Neurosurg. 2020; 55(4):222-231. PMID: 32882694.
      Citations:    Fields:    Translation:Humans
    39. Bashour SI, Ibrahim NK, Schomer DF, Hess KR, Gao C, Tripathy D, Fuller GN. Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype. Br J Cancer. 2020 10; 123(9):1417-1423. PMID: 32747747; PMCID: PMC7591856.
      Citations: 1     Fields:    Translation:Humans
    40. Ott M, Kassab C, Marisetty A, Hashimoto Y, Wei J, Zamler D, Leu JS, Tomaszowski KH, Sabbagh A, Fang D, Gupta P, Priebe W, Zielinski RJ, Burks JK, Long JP, Kong LY, Fuller GN, DeGroot J, Sulman EP, Heimberger AB. Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy. Clin Cancer Res. 2020 09 15; 26(18):4983-4994. PMID: 32605912; PMCID: PMC9341321.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    41. Rao G, Latha K, Ott M, Sabbagh A, Marisetty A, Ling X, Zamler D, Doucette TA, Yang Y, Kong LY, Wei J, Fuller GN, Benavides F, Sonabend AM, Long J, Li S, Curran M, Heimberger AB. Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells. Clin Cancer Res. 2020 09 01; 26(17):4699-4712. PMID: 32554515; PMCID: PMC7483850.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    42. Nam JY, Gilbert A, Cachia D, Mandel J, Fuller GN, Penas-Prado M, de Groot J, Kamiya-Matsuoka C. Pineal parenchymal tumor of intermediate differentiation: a single-institution experience. Neurooncol Pract. 2020 Dec; 7(6):613-619. PMID: 33312675; PMCID: PMC7716182.
      Citations: 3     
    43. Louis DN, Wesseling P, Aldape K, Brat DJ, Cree IA, Eberhart C, Fouladi M, Fuller GN, Giannini C, Haberler C, Hawkins C, Komori T, Kros JM, Ng HK, Orr BA, Park SH, Paulus W, Perry A, Pietsch T, Reifenberger G, Rosenblum M, Rous B, Sahm F, Sarkar C, Solomon DA, Tabori U, van den Bent MJ, von Deimling A, Weller M, White VA, Ellison DW, Capper D, Figarella-Branger D. cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol. 2020 07; 30(4):844-856. PMID: 32307792; PMCID: PMC8018152.
      Citations: 132     Fields:    Translation:Humans
    44. Weathers SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M, Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison R, Majd N, Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G, Weinberg JS, Lang FF, Sawaya R, Shpall EJ, Rezvani K, Heimberger AB. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial. Clin Cancer Res. 2020 07 15; 26(14):3565-3577. PMID: 32299815; PMCID: PMC9347965.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    45. de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549. PMID: 31755915; PMCID: PMC7158647.
      Citations: 41     Fields:    Translation:HumansCells
    46. Ballester LY, Meis JM, Lazar AJ, Prabhu SS, Hoang KB, Leeds NE, Fuller GN. Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion. J Neuropathol Exp Neurol. 2020 03 01; 79(3):347-351. PMID: 32016322.
      Citations: 11     Fields:    Translation:HumansCells
    47. Brat DJ, Aldape K, Colman H, Figrarella-Branger D, Fuller GN, Giannini C, Holland EC, Jenkins RB, Kleinschmidt-DeMasters B, Komori T, Kros JM, Louis DN, McLean C, Perry A, Sarkar C, Stupp R, van den Bent MJ, von Deimling A, Weller M, Reifenberger G. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol. 2020 03; 139(3):603-608. PMID: 31996992; PMCID: PMC8443062.
      Citations: 113     Fields:    Translation:Humans
    48. Li T, Forbes ME, Fuller GN, Li J, Yang X, Zhang W. IGFBP2: integrative hub of developmental and oncogenic signaling network. Oncogene. 2020 03; 39(11):2243-2257. PMID: 31925333; PMCID: PMC7347283.
      Citations: 23     Fields:    Translation:HumansCells
    49. Chen Y, Fang R, Yue C, Chang G, Li P, Guo Q, Wang J, Zhou A, Zhang S, Fuller GN, Shi X, Huang S. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/?-Catenin Target Gene Expression and Glioblastoma Tumorigenesis. Cancer Res. 2020 03 01; 80(5):1049-1063. PMID: 31888886; PMCID: PMC7360480.
      Citations: 18     Fields:    Translation:HumansCells
    50. Fuller G, Araneda P, Sujima E, Paredes-Manzo P, Vallejo R, Valdivia F, Sinning M, Gallegos M. [H3K27 positive diffuse midline glioma. Report of one case]. Rev Med Chil. 2019 Nov; 147(11):1487-1490. PMID: 32186609.
      Citations:    Fields:    Translation:Humans
    51. Santos-Pinheiro F, Penas-Prado M, Kamiya-Matsuoka C, Waguespack SG, Mahajan A, Brown PD, Shah KB, Fuller GN, McCutcheon IE. Treatment and long-term outcomes in pituitary carcinoma: a cohort study. Eur J Endocrinol. 2019 Oct; 181(4):397-407. PMID: 31349217.
      Citations: 9     Fields:    Translation:Humans
    52. Elshafeey N, Kotrotsou A, Hassan A, Elshafei N, Hassan I, Ahmed S, Abrol S, Agarwal A, El Salek K, Bergamaschi S, Acharya J, Moron FE, Law M, Fuller GN, Huse JT, Zinn PO, Colen RR. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat Commun. 2019 07 18; 10(1):3170. PMID: 31320621; PMCID: PMC6639324.
      Citations: 44     Fields:    Translation:Humans
    53. Georgescu MM, Li Y, Islam MZ, Notarianni C, Sun H, Olar A, Fuller GN. Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology-morphological and therapeutic implications. Oncotarget. 2019 Jun 18; 10(40):4038-4052. PMID: 31258848; PMCID: PMC6592288.
      Citations: 6     Fields:    
    54. Marisetty AL, Lu L, Veo BL, Liu B, Coarfa C, Kamal MM, Kassem DH, Irshad K, Lu Y, Gumin J, Henry V, Paulucci-Holthauzen A, Rao G, Baladandayuthapani V, Lang FF, Fuller GN, Majumder S. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro Oncol. 2019 06 10; 21(6):775-785. PMID: 30953587; PMCID: PMC6556851.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    55. Ballester LY, Moghadamtousi SZ, Leeds NE, Huse JT, Fuller GN. Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases. Acta Neuropathol Commun. 2019 04 29; 7(1):63. PMID: 31036092; PMCID: PMC6487516.
      Citations: 6     Fields:    Translation:HumansCells
    56. Zheng S, Alfaro-Munoz K, Wei W, Wang X, Wang F, Eterovic AK, Shaw KRM, Meric-Bernstam F, Fuller GN, Chen K, Verhaak RG, Mills GB, Yung WKA, Weathers SP, de Groot JF. Prospective Clinical Sequencing of Adult Glioma. Mol Cancer Ther. 2019 05; 18(5):991-1000. PMID: 30926639; PMCID: PMC6497568.
      Citations: 5     Fields:    Translation:HumansCells
    57. Gates EDH, Lin JS, Weinberg JS, Hamilton J, Prabhu SS, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout D. Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging. Neuro Oncol. 2019 03 18; 21(4):527-536. PMID: 30657997; PMCID: PMC6422438.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    58. Olar A, Tran D, Mehta VP, Reinhardt A, Manekia JH, Garnovskaya M, Ellezam B, Luthra R, Sulman EP, Mohila CA, Campbell GA, Powell SZ, Fuller GN, Aldape KD, Adesina AM. ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features. Clin Neuropathol. 2019 Mar/Apr; 38(2):59-73. PMID: 30499772.
      Citations: 8     Fields:    Translation:HumansCells
    59. Latha K, Yan J, Yang Y, Gressot LV, Kong LY, Manyam G, Ezhilarasan R, Wang Q, Sulman EP, Eric Davis R, Huang S, Fuller GN, Rao A, Heimberger AB, Li S, Rao G. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma. J Natl Cancer Inst. 2019 03 01; 111(3):292-300. PMID: 29947810; PMCID: PMC6410946.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    60. Majd NK, Metrus NR, Santos-Pinheiro F, Trevino CR, Fuller GN, Huse JT, Chung C, Ketonen L, Anderson MD, Penas-Prado M. RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report. Cancer Genet. 2019 02; 231-232:41-45. PMID: 30803556.
      Citations:    Fields:    Translation:Humans
    61. Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR, Zinn PO. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. J Neurosurg. 2018 12 01; 129(6):1446-1455. PMID: 29328002.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    62. Wei J, Marisetty A, Schrand B, Gabrusiewicz K, Hashimoto Y, Ott M, Grami Z, Kong LY, Ling X, Caruso H, Zhou S, Wang YA, Fuller GN, Huse J, Gilboa E, Kang N, Huang X, Verhaak R, Li S, Heimberger AB. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target. J Clin Invest. 2019 01 02; 129(1):137-149. PMID: 30307407; PMCID: PMC6307970.
      Citations: 98     Fields:    Translation:HumansAnimalsCells
    63. Jonasch E, McCutcheon IE, Gombos DS, Ahrar K, Perrier ND, Liu D, Robichaux CC, Villarreal MF, Weldon JA, Woodson AH, Pilie PG, Fuller GN, Waguespack SG, Matin SF. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359. PMID: 30236511; PMCID: PMC6338228.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    64. Ballester LY, Dunbar E, Guha-Thakurta N, Henson JW, Chandler H, Watkins J, Fuller GN. Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted. Front Neurol. 2018; 9:700. PMID: 30210430; PMCID: PMC6119690.
      Citations:    
    65. Lu L, Marisetty A, Liu B, Kamal MM, Gumin J, Veo B, Cai Y, Kassem DH, Weng C, Maynard ME, Hood KN, Fuller GN, Pan ZZ, Cykowski MD, Dash PK, Majumder S. REST overexpression in mice causes deficits in spontaneous locomotion. Sci Rep. 2018 08 14; 8(1):12083. PMID: 30108242; PMCID: PMC6092433.
      Citations: 3     Fields:    Translation:AnimalsCells
    66. Raza SM, Bell D, Freeman JL, Grosshans DR, Fuller GN, DeMonte F. Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival. Oper Neurosurg (Hagerstown). 2018 08 01; 15(2):131-143. PMID: 29040778.
      Citations: 3     Fields:    Translation:Humans
    67. Du D, Yuan J, Ma W, Ning J, Weinstein JN, Yuan X, Fuller GN, Liu Y. Clinical significance of FBXO17 gene expression in high-grade glioma. BMC Cancer. 2018 Jul 31; 18(1):773. PMID: 30064493; PMCID: PMC6069786.
      Citations: 5     Fields:    Translation:HumansCells
    68. Zinn PO, Singh SK, Kotrotsou A, Hassan I, Thomas G, Luedi MM, Elakkad A, Elshafeey N, Idris T, Mosley J, Gumin J, Fuller GN, de Groot JF, Baladandayuthapani V, Sulman EP, Kumar AJ, Sawaya R, Lang FF, Piwnica-Worms D, Colen RR. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clin Cancer Res. 2018 12 15; 24(24):6288-6299. PMID: 30054278; PMCID: PMC6538261.
      Citations: 37     Fields:    Translation:HumansAnimals
    69. Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM, Undiagnosed Diseases Network, Dhar SU. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma. Neurol Genet. 2018 Aug; 4(4):e248. PMID: 30046660; PMCID: PMC6055357.
      Citations: 4     
    70. Beechar VB, Zinn PO, Heck KA, Fuller GN, Han I, Patel AJ, Ropper AE. Spinal Epidermoid Tumors: Case Report and Review of the Literature. Neurospine. 2018 Jun; 15(2):117-122. PMID: 29991240; PMCID: PMC6104727.
      Citations: 8     
    71. Boulter TD, Sadaka A, Nakawah MO, Smith SV, Alouch N, Berry SE, Whyte AT, Fuller GN, Lee AG. Primary Central Nervous System Lymphoma With Light Chain Deposition Disease (Aggregoma). J Neuroophthalmol. 2018 Jun; 38(2):195-197. PMID: 29280764.
      Citations:    Fields:    Translation:Humans
    72. Wang B, Gogia B, Fuller GN, Ketonen LM. Embryonal Tumor with Multilayered Rosettes, C19MC-Altered: Clinical, Pathological, and Neuroimaging Findings. J Neuroimaging. 2018 09; 28(5):483-489. PMID: 29797626.
      Citations: 8     Fields:    Translation:Humans
    73. Hasanov E, Matin SF, Woodson AHH, Marcott VD, Bird S, Slack RS, Fuller GN, McCutcheon IE, Jonasch E, Pili? P. Pilot study of dovitinib in patients with von Hippel-Lindau disease. Oncotarget. 2018 May 04; 9(34):23390-23395. PMID: 29805741; PMCID: PMC5955100.
      Citations: 5     Fields:    
    74. Ballester LY, Boghani Z, Baskin DS, Britz GW, Olsen R, Fuller GN, Powell SZ, Cykowski MD. Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins. Brain Pathol. 2018 11; 28(6):1012-1019. PMID: 29509313; PMCID: PMC8028565.
      Citations: 2     Fields:    Translation:HumansCells
    75. Ballester LY, Penas-Prado M, Leeds NE, Huse JT, Fuller GN. FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia. Cold Spring Harb Mol Case Stud. 2018 04; 4(2). PMID: 29610389; PMCID: PMC5880259.
      Citations: 7     Fields:    Translation:HumansCells
    76. Lewis GD, Jonasch E, Shah AY, Fuller GN, Farach AM, Butler EB, Teh BS. Renal cell carcinoma brain metastasis with pseudoprogression and radiation necrosis on nivolumab after previous treatment with stereotactic radiosurgery: An illustrative case report and review of the literature. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e262-e265. PMID: 29706304.
      Citations: 3     Fields:    Translation:Humans
    77. Lang FF, Conrad C, Gomez-Manzano C, Yung WKA, Sawaya R, Weinberg JS, Prabhu SS, Rao G, Fuller GN, Aldape KD, Gumin J, Vence LM, Wistuba I, Rodriguez-Canales J, Villalobos PA, Dirven CMF, Tejada S, Valle RD, Alonso MM, Ewald B, Peterkin JJ, Tufaro F, Fueyo J. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol. 2018 05 10; 36(14):1419-1427. PMID: 29432077; PMCID: PMC6075856.
      Citations: 212     Fields:    Translation:HumansCellsCTClinical Trials
    78. Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, Dunner K, Zal MA, Burks JK, Gumin J, Nwajei F, Rezavanian A, Zhou S, Rao G, Sawaya R, Fuller GN, Huse JT, Antel JP, Li S, Cooper L, Sulman EP, Chen C, Geula C, Kalluri R, Zal T, Heimberger AB. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology. 2018; 7(4):e1412909. PMID: 29632728; PMCID: PMC5889290.
      Citations: 122     Fields:    
    79. Gilbert AR, Zaky W, Gokden M, Fuller CE, Ocal E, Leeds NE, Fuller GN. Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin. Pediatr Neurosurg. 2018; 53(1):59-63. PMID: 29131126.
      Citations: 10     Fields:    Translation:Humans
    80. Bell AH, DeMonte F, Raza SM, Rhines LD, Tatsui CE, Prieto VG, Fuller GN, Bell D. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas. Virchows Arch. 2018 Mar; 472(3):489-497. PMID: 28844110.
      Citations: 3     Fields:    Translation:HumansCells
    81. Sun M, Tong P, Kong W, Dong B, Huang Y, Park IY, Zhou L, Liu XD, Ding Z, Zhang X, Bai S, German P, Powell R, Wang Q, Tong X, Tannir NM, Matin SF, Rathmell WK, Fuller GN, McCutcheon IE, Walker CL, Wang J, Jonasch E. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. Cancer Res. 2017 10 01; 77(19):5313-5326. PMID: 28807937; PMCID: PMC5626626.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    82. Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PP, Konopinski J. Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor. Am J Dermatopathol. 2017 Jul; 39(7):545-547. PMID: 28178009.
      Citations:    Fields:    Translation:Humans
    83. Ballester LY, Huse JT, Tang G, Fuller GN. Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results. Hum Pathol. 2017 11; 69:15-22. PMID: 28549927.
      Citations: 12     Fields:    Translation:HumansCells
    84. Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FF. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol. 2017 05 01; 19(5):660-668. PMID: 28453745; PMCID: PMC5464439.
      Citations: 26     Fields:    Translation:HumansCells
    85. Zhao H, Shen J, Hodges TR, Song R, Fuller GN, Heimberger AB. Serum microRNA profiling in patients with glioblastoma: a survival analysis. Mol Cancer. 2017 03 11; 16(1):59. PMID: 28284220; PMCID: PMC5346242.
      Citations: 36     Fields:    Translation:Humans
    86. Powell RT, Olar A, Narang S, Rao G, Sulman E, Fuller GN, Rao A. Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas. J Pathol Inform. 2017; 8:9. PMID: 28382223; PMCID: PMC5364741.
      Citations: 9     
    87. Ballester LY, Fuller GN, Powell SZ, Sulman EP, Patel KP, Luthra R, Routbort MJ. Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors. J Neuropathol Exp Neurol. 2017 03 01; 76(3):179-188. PMID: 28395087.
      Citations: 15     Fields:    Translation:Humans
    88. Gressot LV, Doucette T, Yang Y, Fuller GN, Manyam G, Rao A, Latha K, Rao G. Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma. Oncotarget. 2017 Feb 21; 8(8):12695-12704. PMID: 27074575; PMCID: PMC5355046.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    89. Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BS. Dorsal column myelopathy after intrathecal chemotherapy for leukemia. Am J Hematol. 2017 Feb; 92(2):155-160. PMID: 27874212; PMCID: PMC5338569.
      Citations: 1     Fields:    Translation:Humans
    90. Hu B, Wang Q, Wang YA, Hua S, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, Wang G, Liao WT, Corley LJ, Yan H, Zhang J, You Y, Liu N, Cai L, Finocchiaro G, Phillips JJ, Berger MS, Spring DJ, Hu J, Sulman EP, Fuller GN, Chin L, Verhaak RGW, DePinho RA, Sauv? CG. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 2016 11 17; 167(5):1281-1295.e18. PMID: 27863244; PMCID: PMC5320931.
      Citations: 110     Fields:    Translation:HumansCells
    91. Shingu T, Ho AL, Yuan L, Zhou X, Dai C, Zheng S, Wang Q, Zhong Y, Chang Q, Horner JW, Liebelt BD, Yao Y, Hu B, Chen Y, Fuller GN, Verhaak RG, Heimberger AB, Hu J. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation. Nat Genet. 2017 01; 49(1):75-86. PMID: 27841882; PMCID: PMC5453714.
      Citations: 39     Fields:    Translation:AnimalsCells
    92. Al Sannaa G, Watson KL, Olar A, Wang WL, Fuller GN, McCutcheon I, Torres KE, Lazar AJ. Sarcoma Brain Metastases: 28?Years of Experience at a Single Institution. Ann Surg Oncol. 2016 12; 23(Suppl 5):962-967. PMID: 27646022.
      Citations: 3     Fields:    Translation:Humans
    93. Bell D, Raza SM, Bell AH, Fuller GN, DeMonte F. Whole-transcriptome analysis of chordoma of the skull base. Virchows Arch. 2016 Oct; 469(4):439-49. PMID: 27401718.
      Citations: 6     Fields:    Translation:Humans
    94. Garber ST, Hashimoto Y, Weathers SP, Xiu J, Gatalica Z, Verhaak RG, Zhou S, Fuller GN, Khasraw M, de Groot J, Reddy SK, Spetzler D, Heimberger AB. Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies. Neuro Oncol. 2016 10; 18(10):1357-66. PMID: 27370400; PMCID: PMC5035527.
      Citations: 76     Fields:    Translation:HumansCells
    95. Agnihotri S, Golbourn B, Huang X, Remke M, Younger S, Cairns RA, Chalil A, Smith CA, Krumholtz SL, Mackenzie D, Rakopoulos P, Ramaswamy V, Taccone MS, Mischel PS, Fuller GN, Hawkins C, Stanford WL, Taylor MD, Zadeh G, Rutka JT. PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. Cancer Res. 2016 08 15; 76(16):4708-19. PMID: 27325644.
      Citations: 51     Fields:    Translation:HumansAnimalsCells
    96. Phillips LM, Zhou X, Cogdell DE, Chua CY, Huisinga A, R Hess K, Fuller GN, Zhang W. Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies. J Pathol. 2016 07; 239(3):355-64. PMID: 27125842; PMCID: PMC4915980.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    97. Mandel JJ, Cachia D, Liu D, Wilson C, Aldape K, Fuller G, de Groot JF. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54. PMID: 27270908; PMCID: PMC5021066.
      Citations: 18     Fields:    Translation:Humans
    98. Olar A, Niu N, Jiang Y, Cheng W, Bian XW, Yang W, Zhang J, Yemelyanova A, Malpica A, Zhang Z, Fuller GN, Liu J, Liang L. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016 06; 40(6):847-56. PMID: 26990854; PMCID: PMC4864123.
      Citations: 4     Fields:    Translation:Humans
    99. Xue J, Zhou A, Wu Y, Morris SA, Lin K, Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB, Huang S. miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis. Cancer Res. 2016 07 15; 76(14):4293-304. PMID: 27246830; PMCID: PMC5033679.
      Citations: 43     Fields:    Translation:HumansAnimalsCells
    100. Verla T, Thomas JG, Thomazy V, Fuller GN, Shaibani A, Omeis I. Fulminant spinal cord compression caused by postradiation inflammatory pseudotumor with rapid response to steroids: case report. J Neurosurg Spine. 2016 Nov; 25(5):660-664. PMID: 27231814.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    101. Park SY, Piao Y, Thomas C, Fuller GN, de Groot JF. Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma. Oncotarget. 2016 May 03; 7(18):26793-805. PMID: 27050366; PMCID: PMC5042015.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    102. Ji P, Zhou X, Liu Q, Fuller GN, Phillips LM, Zhang W. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis. Oncotarget. 2016 Apr 26; 7(17):23521-9. PMID: 26993778; PMCID: PMC5029644.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    103. Yust-Katz S, Fuller G, Fichman-Horn S, Michaeli N, Inbar E, Lukman J, Limon D, Steiner I, Siegal T. Progressive diffuse meningioangiomatosis: Response to bevacizumab treatment. Neurology. 2016 04 26; 86(17):1643-4. PMID: 27029633; PMCID: PMC4844238.
      Citations:    Fields:    Translation:Humans
    104. Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger AB. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight. 2016; 1(2). PMID: 26973881; PMCID: PMC4784261.
      Citations: 194     Fields:    
    105. Kong LY, Wei J, Fuller GN, Schrand B, Gabrusiewicz K, Zhou S, Rao G, Calin G, Gilboa E, Heimberger AB. Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. Oncoimmunology. 2016 May; 5(5):e1117739. PMID: 27467917; PMCID: PMC4910740.
      Citations: 5     Fields:    
    106. Wei J, Nduom EK, Kong LY, Hashimoto Y, Xu S, Gabrusiewicz K, Ling X, Huang N, Qiao W, Zhou S, Ivan C, Fuller GN, Gilbert MR, Overwijk W, Calin GA, Heimberger AB. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro Oncol. 2016 05; 18(5):639-48. PMID: 26658052; PMCID: PMC4827047.
      Citations: 88     Fields:    Translation:HumansAnimalsCells
    107. Liang L, Zhang Y, Malpica A, Ramalingam P, Euscher ED, Fuller GN, Liu J. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases. Mod Pathol. 2015 Dec; 28(12):1613-20. PMID: 26564007; PMCID: PMC4682736.
      Citations: 13     Fields:    Translation:Humans
    108. Sathyan P, Zinn PO, Marisetty AL, Liu B, Kamal MM, Singh SK, Bady P, Lu L, Wani KM, Veo BL, Gumin J, Kassem DH, Robinson F, Weng C, Baladandayuthapani V, Suki D, Colman H, Bhat KP, Sulman EP, Aldape K, Colen RR, Verhaak RG, Lu Z, Fuller GN, Huang S, Lang FF, Sawaya R, Hegi M, Majumder S. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. J Neurosci. 2015 Nov 11; 35(45):15097-112. PMID: 26558781; PMCID: PMC4642241.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    109. Cachia D, Kamiya-Matsuoka C, Mandel JJ, Olar A, Cykowski MD, Armstrong TS, Fuller GN, Gilbert MR, De Groot JF. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10. PMID: 26354773; PMCID: PMC8323586.
      Citations: 22     Fields:    Translation:Humans
    110. Liu Q, Liu Y, Li W, Wang X, Sawaya R, Lang FF, Yung WK, Chen K, Fuller GN, Zhang W. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathol. 2015 Oct; 130(4):587-97. PMID: 26323991; PMCID: PMC4776337.
      Citations: 29     Fields:    Translation:HumansCells
    111. Nduom EK, Wei J, Yaghi NK, Huang N, Kong LY, Gabrusiewicz K, Ling X, Zhou S, Ivan C, Chen JQ, Burks JK, Fuller GN, Calin GA, Conrad CA, Creasy C, Ritthipichai K, Radvanyi L, Heimberger AB. PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol. 2016 Feb; 18(2):195-205. PMID: 26323609; PMCID: PMC4724183.
      Citations: 235     Fields:    Translation:HumansAnimalsCells
    112. Saade R, Hessel A, Ginsberg L, Fuller G, Bell D. Primary extradural meningioma presenting as a neck mass: Case report and review of the literature. Head Neck. 2015 Aug; 37(8):E92-5. PMID: 25251307.
      Citations:    Fields:    Translation:Humans
    113. Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, Mclendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, Wolinsky Y, Bell S, Rosenberg M, Stewart C, Huang F, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98. PMID: 26061751; PMCID: PMC4530011.
      Citations: 1192     Fields:    Translation:HumansCells
    114. Lau SK, Cykowski MD, Desai S, Cao Y, Fuller GN, Bruner J, Okazaki I. Primary rhabdomyosarcoma of the pineal gland. Am J Clin Pathol. 2015 May; 143(5):728-33. PMID: 25873508.
      Citations: 1     Fields:    Translation:Humans
    115. Edson MA, Fuller GN, Allen PK, Levine NB, Ghia AJ, Mahajan A, Brown PD, DeMonte F, Li J. Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. World Neurosurg. 2015 Jul; 84(1):76-81. PMID: 25749579.
      Citations: 5     Fields:    Translation:Humans
    116. Turner KM, Sun Y, Ji P, Granberg KJ, Bernard B, Hu L, Cogdell DE, Zhou X, Yli-Harja O, Nykter M, Shmulevich I, Yung WK, Fuller GN, Zhang W. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression. Proc Natl Acad Sci U S A. 2015 Mar 17; 112(11):3421-6. PMID: 25737557; PMCID: PMC4371922.
      Citations: 55     Fields:    Translation:HumansAnimalsCells
    117. Phillips J, Tihan T, Fuller G. Practical molecular pathology and histopathology of embryonal tumors. Surg Pathol Clin. 2015 Mar; 8(1):73-88. PMID: 25783823.
      Citations: 1     Fields:    Translation:Humans
    118. Cachia D, Prado MP, Theeler B, Hamilton J, McCutcheon I, Fuller GN. Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report. Clin Neuropathol. 2014 Nov-Dec; 33(6):407-11. PMID: 24986181.
      Citations: 6     Fields:    Translation:Humans
    119. Kong LY, Wei J, Haider AS, Liebelt BD, Ling X, Conrad CA, Fuller GN, Levine NB, Priebe W, Sawaya R, Heimberger AB. Therapeutic targets in subependymoma. J Neuroimmunol. 2014 Dec 15; 277(1-2):168-75. PMID: 25465288.
      Citations: 6     Fields:    Translation:HumansCells
    120. Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KD. Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathol. 2015 May; 25(3):266-75. PMID: 25040885; PMCID: PMC4297750.
      Citations: 36     Fields:    Translation:HumansCells
    121. Gressot LV, Doucette TA, Yang Y, Fuller GN, Heimberger AB, Rao A, Latha K, Rao G, B?gler O. Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis. Int J Cancer. 2015 May 01; 136(9):2047-54. PMID: 25302990; PMCID: PMC4331224.
      Citations: 7     Fields:    Translation:Animals
    122. Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov A, Kros JM, Beatriz Lopes M, Ng HK, Ohgaki H, Paulus W, Pietsch T, Rosenblum M, Rushing E, Soylemezoglu F, Wiestler O, Wesseling P, International Society Of Neuropathology--Haarlem. International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 2014 Sep; 24(5):429-35. PMID: 24990071; PMCID: PMC8029490.
      Citations: 234     Fields:    Translation:Humans
    123. Davoudi S, Anderlini P, Fuller GN, Kontoyiannis DP. A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case. Mycopathologia. 2014 Dec; 178(5-6):465-70. PMID: 25086667.
      Citations: 15     Fields:    Translation:HumansAnimals
    124. Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014 Aug; 106(8). PMID: 24974128; PMCID: PMC4271080.
      Citations: 62     Fields:    Translation:HumansAnimalsCells
    125. Mukherjee M, Byrd T, Brawley VS, Bielamowicz K, Li XN, Merchant F, Maitra S, Sumazin P, Fuller G, Kew Y, Sun D, Powell SZ, Ahmed N, Zhang N, Pati D. Overexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme. J Neurooncol. 2014 Aug; 119(1):27-35. PMID: 24792645; PMCID: PMC4160150.
      Citations: 15     Fields:    Translation:HumansCells
    126. Gabrusiewicz K, Liu D, Cortes-Santiago N, Hossain MB, Conrad CA, Aldape KD, Fuller GN, Marini FC, Alonso MM, Idoate MA, Gilbert MR, Fueyo J, Gomez-Manzano C. Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes. Oncotarget. 2014 Apr 30; 5(8):2208-20. PMID: 24809734; PMCID: PMC4039157.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    127. Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, Nykter M, Shmulevich I, Fuller GN, Lang FF, Zhang W. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015 Mar 26; 34(13):1619-1628. PMID: 24747968; PMCID: PMC4205227.
      Citations: 48     Fields:    Translation:HumansAnimalsCells
    128. Doucette T, Latha K, Yang Y, Fuller GN, Rao A, Rao G. Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas. Neuro Oncol. 2014 Sep; 16(9):1220-8. PMID: 24676140; PMCID: PMC4136894.
      Citations: 6     Fields:    Translation:HumansAnimals
    129. Yust-Katz S, Anderson MD, Liu D, Wu J, Yuan Y, Olar A, Fuller GN, Brown PD, de-Groot JF. Clinical and prognostic features of adult patients with gangliogliomas. Neuro Oncol. 2014 Mar; 16(3):409-13. PMID: 24305706; PMCID: PMC3922509.
      Citations: 13     Fields:    Translation:Humans
    130. Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N, de Groot JF. Neutrophils promote the malignant glioma phenotype through S100A4. Clin Cancer Res. 2014 Jan 01; 20(1):187-98. PMID: 24240114; PMCID: PMC4422653.
      Citations: 112     Fields:    Translation:HumansAnimalsCells
    131. Pong WW, Walker J, Wylie T, Magrini V, Luo J, Emnett RJ, Choi J, Cooper ML, Griffith M, Griffith OL, Rubin JB, Fuller GN, Piwnica-Worms D, Feng X, Hambardzumyan D, DiPersio JF, Mardis ER, Gutmann DH. F11R is a novel monocyte prognostic biomarker for malignant glioma. PLoS One. 2013; 8(10):e77571. PMID: 24147027; PMCID: PMC3795683.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    132. George AA, Fuller GN, Langford LA, Simon CD, Zingalis AA, Mathis DA. Unusual presentation of a granular cell astrocytoma. Histopathology. 2013 Dec; 63(6):883-5. PMID: 24102930.
      Citations: 1     Fields:    Translation:Humans
    133. Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013 Jul 01; 73(13):3913-26. PMID: 23636127; PMCID: PMC3780786.
      Citations: 126     Fields:    Translation:HumansAnimalsCells
    134. Tahmasebi FC, Farmer P, Powell SZ, Aldape KD, Fuller GN, Patel S, Hollis P, Chalif D, Eisenberg MB, Li JY. Brain metastases from papillary thyroid carcinomas. Virchows Arch. 2013 Apr; 462(4):473-80. PMID: 23532501.
      Citations: 6     Fields:    Translation:Humans
    135. Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, Liu X, Liu CG, Sawaya R, Yli-Harja O, Shmulevich I, Fuller GN, Zhang W, Nykter M. Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma. J Pathol. 2013 Feb; 229(3):449-59. PMID: 23007860; PMCID: PMC3857031.
      Citations: 13     Fields:    Translation:HumansCells
    136. Parker BC, Annala MJ, Cogdell DE, Granberg KJ, Sun Y, Ji P, Li X, Gumin J, Zheng H, Hu L, Yli-Harja O, Haapasalo H, Visakorpi T, Liu X, Liu CG, Sawaya R, Fuller GN, Chen K, Lang FF, Nykter M, Zhang W. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest. 2013 Feb; 123(2):855-65. PMID: 23298836; PMCID: PMC3561838.
      Citations: 114     Fields:    Translation:HumansAnimalsCells
    137. Hightower E, Cabanillas ME, Fuller GN, McCutcheon IE, Hess KR, Shah K, Waguespack SG, Corley LJ, Devin JK. Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas. Pituitary. 2012 Dec; 15(4):556-61. PMID: 22120760; PMCID: PMC3852837.
      Citations: 5     Fields:    Translation:HumansCells
    138. Theeler BJ, Yung WK, Fuller GN, De Groot JF. Moving toward molecular classification of diffuse gliomas in adults. Neurology. 2012 Oct 30; 79(18):1917-26. PMID: 23109653; PMCID: PMC3525311.
      Citations: 33     Fields:    Translation:Humans
    139. Gadgil N, Kupferman M, Smitherman S, Fuller GN, Rao G. Curvularia brain abscess. J Clin Neurosci. 2013 Jan; 20(1):173-5. PMID: 22989791.
      Citations: 4     Fields:    Translation:HumansAnimals
    140. de Groot J, Liang J, Kong LY, Wei J, Piao Y, Fuller G, Qiao W, Heimberger AB. Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma. Oncotarget. 2012 Sep; 3(9):1036-48. PMID: 23013619; PMCID: PMC3660053.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    141. Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KD. Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathol. 2012 Sep; 124(3):449-51. PMID: 22772980; PMCID: PMC4085739.
      Citations: 27     Fields:    Translation:Humans
    142. Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K, Priebe W, Heimberger AB, Rao G, B?gler O. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol. 2012 Sep; 14(9):1136-45. PMID: 22753228; PMCID: PMC3424209.
      Citations: 48     Fields:    Translation:HumansAnimalsCells
    143. Li JY, Lopez JI, Powell SZ, Coons SW, Fuller GN. Giant cell ependymoma-report of three cases and review of the literature. Int J Clin Exp Pathol. 2012; 5(5):458-62. PMID: 22808300; PMCID: PMC3396061.
      Citations: 4     Fields:    Translation:HumansCells
    144. Raghunathan A, Olar A, Vogel H, Parker JR, Coventry SC, Debski R, Albarracin CT, Aldape KD, Cahill DP, Powell SZ, Fuller GN. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Ann Diagn Pathol. 2012 Aug; 16(4):255-9. PMID: 22445362.
      Citations: 3     Fields:    Translation:Humans
    145. Lee I, Fox PS, Ferguson SD, Bassett R, Kong LY, Schacherer CW, Gershenwald JE, Grimm EA, Fuller GN, Heimberger AB. The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival. Oncotarget. 2012 Mar; 3(3):336-44. PMID: 22488042; PMCID: PMC3359889.
      Citations: 12     Fields:    Translation:HumansCells
    146. Kamal MM, Sathyan P, Singh SK, Zinn PO, Marisetty AL, Liang S, Gumin J, El-Mesallamy HO, Suki D, Colman H, Fuller GN, Lang FF, Majumder S. REST regulates oncogenic properties of glioblastoma stem cells. Stem Cells. 2012 Mar; 30(3):405-14. PMID: 22228704; PMCID: PMC4039365.
      Citations: 47     Fields:    Translation:AnimalsCells
    147. Holmes KM, Annala M, Chua CY, Dunlap SM, Liu Y, Hugen N, Moore LM, Cogdell D, Hu L, Nykter M, Hess K, Fuller GN, Zhang W. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-?B network. Proc Natl Acad Sci U S A. 2012 Feb 28; 109(9):3475-80. PMID: 22345562; PMCID: PMC3295320.
      Citations: 62     Fields:    Translation:HumansAnimalsCells
    148. Olar A, Raghunathan A, Albarracin CT, Aldape KD, Cahill DP, Powell SZ, Goodman JC, Fuller GN. Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Ann Diagn Pathol. 2012 Jun; 16(3):161-70. PMID: 22197544.
      Citations: 14     Fields:    Translation:Humans
    149. Li JY, Langford LA, Adesina A, Bodhireddy SR, Wang M, Fuller GN. The high mitotic count detected by phospho-histone H3 immunostain does not alter the benign behavior of angiocentric glioma. Brain Tumor Pathol. 2012 Jan; 29(1):68-72. PMID: 21892765.
      Citations: 7     Fields:    Translation:Humans
    150. Hatiboglu MA, Kong LY, Wei J, Wang Y, McEnery KA, Fuller GN, Qiao W, Davies MA, Priebe W, Heimberger AB. The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models. Int J Cancer. 2012 Jul 01; 131(1):8-17. PMID: 21792892; PMCID: PMC3319790.
      Citations: 13     Fields:    Translation:AnimalsCells
    151. Xu J, Sampath D, Lang FF, Prabhu S, Rao G, Fuller GN, Liu Y, Puduvalli VK. Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures. J Neurooncol. 2011 Nov; 105(2):241-51. PMID: 21598070; PMCID: PMC3794467.
      Citations: 23     Fields:    Translation:HumansCells
    152. Singh A, Rokes C, Gireud M, Fletcher S, Baumgartner J, Fuller G, Stewart J, Zage P, Gopalakrishnan V. Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(?-TRCP) in neuroblastoma cells. Cancer. 2011 Nov 15; 117(22):5189-202. PMID: 21523764.
      Citations: 25     Fields:    Translation:HumansCells
    153. Agnihotri S, Wolf A, Munoz DM, Smith CJ, Gajadhar A, Restrepo A, Clarke ID, Fuller GN, Kesari S, Dirks PB, McGlade CJ, Stanford WL, Aldape K, Mischel PS, Hawkins C, Guha A. A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. J Exp Med. 2011 Apr 11; 208(4):689-702. PMID: 21464220; PMCID: PMC3135351.
      Citations: 37     Fields:    Translation:HumansAnimalsCells
    154. Cogdell D, Chung W, Liu Y, McDonald JM, Aldape K, Issa JP, Fuller GN, Zhang W. Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma. Chin J Cancer. 2011 Apr; 30(4):247-53. PMID: 21439246; PMCID: PMC4013351.
      Citations: 12     Fields:    Translation:HumansCells
    155. Doucette T, Yang Y, Zhang W, Fuller GN, Suki D, Fults DW, Rao G. Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma. Int J Cancer. 2011 Nov 01; 129(9):2093-103. PMID: 21171016; PMCID: PMC3196817.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    156. Moore LM, Holmes KM, Fuller GN, Zhang W. Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model. Chin J Cancer. 2011 Mar; 30(3):163-72. PMID: 21352693; PMCID: PMC4013312.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    157. Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM. Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol. 2011 Feb; 196(2):W187-93. PMID: 21257861.
      Citations: 27     Fields:    Translation:Humans
    158. Wei J, Wu A, Kong LY, Wang Y, Fuller G, Fokt I, Melillo G, Priebe W, Heimberger AB. Hypoxia potentiates glioma-mediated immunosuppression. PLoS One. 2011 Jan 20; 6(1):e16195. PMID: 21283755; PMCID: PMC3024401.
      Citations: 94     Fields:    Translation:HumansCells
    159. Staquicini FI, Ozawa MG, Moya CA, Driessen WH, Barbu EM, Nishimori H, Soghomonyan S, Flores LG, Liang X, Paolillo V, Alauddin MM, Basilion JP, Furnari FB, Bogler O, Lang FF, Aldape KD, Fuller GN, Gelovani JG, Sidman RL, Cavenee WK, Pasqualini R, Arap W, H??k M. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011 Jan; 121(1):161-73. PMID: 21183793; PMCID: PMC3007161.
      Citations: 61     Fields:    Translation:HumansAnimalsCells
    160. Bell D, Gidley P, Levine N, Fuller GN. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience. Ann Diagn Pathol. 2011 Apr; 15(2):117-23. PMID: 21167761.
      Citations: 13     Fields:    Translation:Humans
    161. Kong LY, Wu AS, Doucette T, Wei J, Priebe W, Fuller GN, Qiao W, Sawaya R, Rao G, Heimberger AB. Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses. Clin Cancer Res. 2010 Dec 01; 16(23):5722-33. PMID: 20921210; PMCID: PMC2999668.
      Citations: 44     Fields:    Translation:HumansAnimals
    162. Gopalakrishnan V, Bie B, Sinnappah-Kang ND, Adams H, Fuller GN, Pan ZZ, Majumder S. Myoblast-derived neuronal cells form glutamatergic neurons in the mouse cerebellum. Stem Cells. 2010 Oct; 28(10):1839-47. PMID: 20799335; PMCID: PMC3063457.
      Citations: 4     Fields:    Translation:AnimalsCells
    163. Mendes KN, Wang GK, Fuller GN, Zhang W. JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration. Int J Oncol. 2010 Jul; 37(1):143-53. PMID: 20514406.
      Citations: 22     Fields:    Translation:HumansCells
    164. Kumar AJ, Leeds NE, Kumar VA, Fuller GN, Lang FF, Milas Z, Weinberg JS, Ater JL, Sawaya R. Magnetic resonance imaging features of pilocytic astrocytoma of the brain mimicking high-grade gliomas. J Comput Assist Tomogr. 2010 Jul; 34(4):601-11. PMID: 20657231.
      Citations: 5     Fields:    Translation:Humans
    165. Perry A, Burton SS, Fuller GN, Robinson CA, Palmer CA, Resch L, Bigio EH, Gujrati M, Rosenblum MK. Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall. Acta Neuropathol. 2010 Aug; 120(2):237-52. PMID: 20464403; PMCID: PMC2892612.
      Citations: 12     Fields:    Translation:HumansCells
    166. Rao P, Fuller GN, Prieto VG. Expression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall. Am J Dermatopathol. 2010 May; 32(3):262-266. PMID: 20098296.
      Citations: 8     Fields:    Translation:HumansCells
    167. Hassaneen W, Suki D, Salaskar AL, Wildrick DM, Lang FF, Fuller GN, Sawaya R. Surgical management of lateral-ventricle metastases: report of 29 cases in a single-institution experience. J Neurosurg. 2010 May; 112(5):1046-55. PMID: 19663549.
      Citations: 8     Fields:    Translation:Humans
    168. Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger AB. Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Clin Cancer Res. 2010 May 01; 16(9):2550-61. PMID: 20388845; PMCID: PMC2936966.
      Citations: 23     Fields:    Translation:AnimalsCells
    169. de Groot JF, Fuller G, Kumar AJ, Piao Y, Eterovic K, Ji Y, Conrad CA. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol. 2010 Mar; 12(3):233-42. PMID: 20167811; PMCID: PMC2940588.
      Citations: 258     Fields:    Translation:HumansAnimals
    170. Wu Y, Song SW, Sun J, Bruner JM, Fuller GN, Zhang W. IIp45 inhibits cell migration through inhibition of HDAC6. J Biol Chem. 2010 Feb 05; 285(6):3554-3560. PMID: 20008322; PMCID: PMC2823495.
      Citations: 25     Fields:    Translation:HumansCells
    171. Higgins RJ, Dickinson PJ, LeCouteur RA, Bollen AW, Wang H, Wang H, Corely LJ, Moore LM, Zang W, Fuller GN. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. J Neurooncol. 2010 May; 98(1):49-55. PMID: 19967449.
      Citations: 34     Fields:    Translation:Animals
    172. Humphries W, Wang Y, Qiao W, Reina-Ortiz C, Abou-Ghazal MK, Crutcher LM, Wei J, Kong LY, Sawaya R, Rao G, Weinberg J, Prabhu SS, Fuller GN, Heimberger AB. yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients. J Transl Med. 2009 Nov 09; 7:92. PMID: 19900287; PMCID: PMC2777138.
      Citations: 4     Fields:    Translation:HumansCells
    173. Hassaneen W, Cahill DP, Fuller GN, Levine NB. Immunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma. J Neurooncol. 2010 May; 98(1):151-2. PMID: 19894022.
      Citations: 1     Fields:    Translation:Humans
    174. Rokes C, Ketonen LM, Fuller GN, Weinberg J, Slopis JM, Wolff JE. Imaging and spectroscopic findings in meningioangiomatosis. Pediatr Blood Cancer. 2009 Oct; 53(4):672-4. PMID: 19544396.
      Citations: 3     Fields:    Translation:Humans
    175. Moore LM, Holmes KM, Smith SM, Wu Y, Tchougounova E, Uhrbom L, Sawaya R, Bruner JM, Fuller GN, Zhang W. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas. Proc Natl Acad Sci U S A. 2009 Sep 29; 106(39):16675-9. PMID: 19805356; PMCID: PMC2757856.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    176. Rodney AJ, Gombos DS, Fuller GN, Pagliaro LC, Tannir NM. Choroidal and conjunctival metastases from renal cell carcinoma. Am J Clin Oncol. 2009 Aug; 32(4):448-9. PMID: 19657240.
      Citations: 5     Fields:    Translation:Humans
    177. Gilcrease MZ, Woodward WA, Nicolas MM, Corley LJ, Fuller GN, Esteva FJ, Tucker SL, Buchholz TA. Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer. Am J Surg Pathol. 2009 May; 33(5):759-67. PMID: 19252432; PMCID: PMC3063383.
      Citations: 32     Fields:    Translation:Humans
    178. Aguilera DG, Das CM, Sinnappah-Kang ND, Joyce C, Taylor PH, Wen S, Hasselblatt M, Paulus W, Fuller G, Wolff JE, Gopalakrishnan V. Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL. J Neurooncol. 2009 Jul; 93(3):303-18. PMID: 19148581; PMCID: PMC3820292.
      Citations: 20     Fields:    Translation:HumansCells
    179. Giuliari GP, Banda RM, Fuller GN, Gombos DS, Vann VR, Ch?vez-Barrios P. Choroidal melanoma masquerading as panuveitis in a patient with multiple myeloma. Retin Cases Brief Rep. 2009; 3(2):152-5. PMID: 25391061.
      Citations:    Fields:    
    180. Heimberger AB, Kong LY, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Wei J, Qiao W, Schmittling RJ, Archer GE, Sampson JH, Hiraoka N, Priebe W, Fuller GN, Sawaya R. The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. Clin Neurosurg. 2009; 56:98-106. PMID: 20214040.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    181. Gilcrease MZ, Kilpatrick SK, Woodward WA, Zhou X, Nicolas MM, Corley LJ, Fuller GN, Tucker SL, Diaz LK, Buchholz TA, Frost JA. Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):80-6. PMID: 19124484; PMCID: PMC2669542.
      Citations: 24     Fields:    Translation:HumansCells
    182. Abou-Ghazal M, Yang DS, Qiao W, Reina-Ortiz C, Wei J, Kong LY, Fuller GN, Hiraoka N, Priebe W, Sawaya R, Heimberger AB. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res. 2008 Dec 15; 14(24):8228-35. PMID: 19088040; PMCID: PMC2605668.
      Citations: 97     Fields:    Translation:HumansCells
    183. Kuo SH, Debnam JM, Fuller GN, de Groot J. Wernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patients. Oncology. 2009; 76(1):10-8. PMID: 19018150.
      Citations: 19     Fields:    Translation:Humans
    184. Kong LY, Abou-Ghazal MK, Wei J, Chakraborty A, Sun W, Qiao W, Fuller GN, Fokt I, Grimm EA, Schmittling RJ, Archer GE, Sampson JH, Priebe W, Heimberger AB. A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells. Clin Cancer Res. 2008 Sep 15; 14(18):5759-68. PMID: 18794085; PMCID: PMC2583362.
      Citations: 68     Fields:    Translation:AnimalsCells
    185. Heimberger AB, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Sun W, Qiao W, Hiraoka N, Fuller GN. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin Cancer Res. 2008 Aug 15; 14(16):5166-72. PMID: 18698034.
      Citations: 160     Fields:    Translation:HumansCells
    186. Amini E, Roffidal T, Lee A, Fuller GN, Mahajan A, Ketonen L, Kobrinsky N, Cairo MS, Wells RJ, Wolff JE. Central neurocytoma responsive to topotecan, ifosfamide, carboplatin. Pediatr Blood Cancer. 2008 Jul; 51(1):137-40. PMID: 18338396.
      Citations: 7     Fields:    Translation:Humans
    187. Scheithauer BW, Fuller GN, VandenBerg SR. The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathol. 2008 Jul; 18(3):307-16. PMID: 18532929; PMCID: PMC8095595.
      Citations: 24     Fields:    Translation:Humans
    188. Raslan O, Ketonen LM, Fuller GN, Schellingerhout D. Intracranial Rosai-Dorfman disease with relapsing spinal lesions. J Clin Oncol. 2008 Jun 20; 26(18):3087-9. PMID: 18565897.
      Citations: 9     Fields:    Translation:Humans
    189. Fuller GN. The WHO Classification of Tumours of the Central Nervous System, 4th edition. Arch Pathol Lab Med. 2008 Jun; 132(6):906. PMID: 18517270.
      Citations: 32     Fields:    Translation:Humans
    190. de Groot JF, Piao Y, Lu L, Fuller GN, Yung WK. Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol. 2008 Jun; 88(2):121-33. PMID: 18317690.
      Citations: 37     Fields:    Translation:HumansAnimalsCells
    191. Masoudi A, Amini E, Wolff JE, Fuller GN, Ketonen L, Mahajan A. Shrinkage of germinoma by dexamethasone only. Pediatr Blood Cancer. 2008 May; 50(5):1079. PMID: 18000859.
      Citations:    Fields:    Translation:Humans
    192. Wang H, Arun BK, Wang H, Fuller GN, Zhang W, Middleton LP, Sahin AA. IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas. Breast J. 2008 May-Jun; 14(3):261-7. PMID: 18373644.
      Citations: 25     Fields:    Translation:Humans
    193. Li JY, Wang H, May S, Song X, Fueyo J, Fuller GN, Wang H. Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas. J Neurooncol. 2008 May; 88(1):11-7. PMID: 18246408.
      Citations: 28     Fields:    Translation:HumansCells
    194. Yoo JH, Rivera A, Naeini RM, Yedururi S, Bayindir P, Megahead H, Fuller GN, Suh JS, Adesina AM, Hunter JV. Melanotic paraganglioma arising in the temporal horn following Langerhans cell histiocytosis. Pediatr Radiol. 2008 May; 38(5):571-4. PMID: 18196230.
      Citations: 1     Fields:    Translation:Humans
    195. Liang JJ, Alrawi S, Fuller GN, Tan D. Carcinoid tumors arising in tailgut cysts may be associated with estrogen receptor status: case report and review of the literature. Int J Clin Exp Pathol. 2008 Jan 01; 1(6):539-43. PMID: 18787681; PMCID: PMC2480588.
      Citations: 13     Fields:    
    196. Williams MD, Asa SL, Fuller GN. Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol. 2008 Jun; 12(3):199-203. PMID: 18486896.
      Citations: 10     Fields:    Translation:Humans
    197. McCutcheon IE, Waguespack SG, Fuller GN, Couldwell WT. Metastatic melanoma to the pituitary gland. Can J Neurol Sci. 2007 Aug; 34(3):322-7. PMID: 17803030.
      Citations: 11     Fields:    Translation:Humans
    198. Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN, Zhang W. Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci U S A. 2007 Jul 10; 104(28):11736-41. PMID: 17606927; PMCID: PMC1913900.
      Citations: 67     Fields:    Translation:HumansAnimalsCells
    199. Zhang W, Fuller G. IGFBP2 as a brain tumor oncogene. Cancer Biol Ther. 2007 Jul; 6(7):995-6. PMID: 19358341.
      Citations: 4     Fields:    Translation:Humans
    200. Fuller GN, Scheithauer BW. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol. 2007 Jul; 17(3):304-7. PMID: 17598822; PMCID: PMC8095523.
      Citations: 81     Fields:    Translation:Humans
    201. Brat DJ, Scheithauer BW, Fuller GN, Tihan T. Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol. 2007 Jul; 17(3):319-24. PMID: 17598825; PMCID: PMC8095654.
      Citations: 55     Fields:    Translation:HumansCells
    202. Barnett JA, Urbauer DL, Murray GI, Fuller GN, Heimberger AB. Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target. Clin Cancer Res. 2007 Jun 15; 13(12):3559-67. PMID: 17575219.
      Citations: 10     Fields:    Translation:Humans
    203. Olson MV, Johnson DG, Jiang H, Xu J, Alonso MM, Aldape KD, Fuller GN, Bekele BN, Yung WK, Gomez-Manzano C, Fueyo J. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 2007 May 01; 67(9):4005-9. PMID: 17483310.
      Citations: 12     Fields:    Translation:HumansAnimals
    204. Lee OH, Xu J, Fueyo J, Fuller GN, Aldape KD, Alonso MM, Piao Y, Liu TJ, Lang FF, Bekele BN, Gomez-Manzano C. Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res. 2006 Dec; 4(12):915-26. PMID: 17189382.
      Citations: 34     Fields:    Translation:HumansCells
    205. Fuller GN. Narrowing the differential diagnosis in surgical neuropathology. Arch Pathol Lab Med. 2006 Nov; 130(11):1602. PMID: 17076519.
      Citations:    Fields:    Translation:Humans
    206. Xu JJ, Walla BC, Diaz MF, Fuller GN, Gutstein HB. Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance. Anesth Analg. 2006 Sep; 103(3):714-20. PMID: 16931686.
      Citations: 40     Fields:    Translation:Animals
    207. Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, Fuller GN, Aldape KD. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res. 2006 Jul 01; 12(13):3935-41. PMID: 16818690.
      Citations: 79     Fields:    Translation:HumansCells
    208. Wang H, Wang H, Zhang W, Fuller GN. Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat. 2006 Jun; 5(3):195-9. PMID: 16700616.
      Citations: 15     Fields:    Translation:HumansCells
    209. Wang H, Rosen DG, Wang H, Fuller GN, Zhang W, Liu J. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol. 2006 Sep; 19(9):1149-56. PMID: 16729015.
      Citations: 29     Fields:    Translation:Humans
    210. Cheung HC, Corley LJ, Fuller GN, McCutcheon IE, Cote GJ. Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod Pathol. 2006 Aug; 19(8):1034-41. PMID: 16729017.
      Citations: 29     Fields:    Translation:Humans
    211. Jiang R, Mircean C, Shmulevich I, Cogdell D, Jia Y, Tabus I, Aldape K, Sawaya R, Bruner JM, Fuller GN, Zhang W. Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics. 2006 May; 6(10):2964-71. PMID: 16619307.
      Citations: 27     Fields:    Translation:HumansCells
    212. Lee OH, Fueyo J, Xu J, Yung WK, Lemoine MG, Lang FF, Bekele BN, Zhou X, Alonso MA, Aldape KD, Fuller GN, Gomez-Manzano C. Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia. 2006 May; 8(5):419-28. PMID: 16790091; PMCID: PMC1592446.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    213. Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol. 2006 May; 30(5):657-64. PMID: 16699322.
      Citations: 51     Fields:    Translation:Humans
    214. Levin VA, Phuphanich S, Yung WK, Forsyth PA, Maestro RD, Perry JR, Fuller GN, Baillet M. Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation. J Neurooncol. 2006 Jul; 78(3):295-302. PMID: 16636750.
      Citations: 43     Fields:    Translation:Humans
    215. Leeds NE, Lang FF, Ribalta T, Sawaya R, Fuller GN. Origin of chordoid glioma of the third ventricle. Arch Pathol Lab Med. 2006 Apr; 130(4):460-4. PMID: 16594739.
      Citations: 14     Fields:    Translation:Humans
    216. Wang L, Wei Q, Wang LE, Aldape KD, Cao Y, Okcu MF, Hess KR, El-Zein R, Gilbert MR, Woo SY, Prabhu SS, Fuller GN, Bondy ML. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol. 2006 Apr 01; 24(10):1627-32. PMID: 16575014.
      Citations: 30     Fields:    Translation:Humans
    217. Wang GK, Hu L, Fuller GN, Zhang W. An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility. J Biol Chem. 2006 May 19; 281(20):14085-91. PMID: 16569642.
      Citations: 55     Fields:    Translation:HumansCells
    218. McDonald JM, Dunlap S, Cogdell D, Dunmire V, Wei Q, Starzinski-Powitz A, Sawaya R, Bruner J, Fuller GN, Aldape K, Zhang W. The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration. Cancer Biol Ther. 2006 Mar; 5(3):300-4. PMID: 16410724.
      Citations: 22     Fields:    Translation:HumansCells
    219. Huo L, Moran CA, Fuller GN, Gladish G, Suster S. Pulmonary artery sarcoma: a clinicopathologic and immunohistochemical study of 12 cases. Am J Clin Pathol. 2006 Mar; 125(3):419-24. PMID: 16613346.
      Citations: 33     Fields:    Translation:Humans
    220. Su X, Gopalakrishnan V, Stearns D, Aldape K, Lang FF, Fuller G, Snyder E, Eberhart CG, Majumder S. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol Cell Biol. 2006 Mar; 26(5):1666-78. PMID: 16478988; PMCID: PMC1430235.
      Citations: 76     Fields:    Translation:HumansAnimalsCells
    221. Costelloe CM, Fuller GN, Kumar AJ, Cline K, Neitzschman HR. Radiology case of the month. Palmar mass and finger weakness. Fibrolipomatous hamartoma. J La State Med Soc. 2006 Jan-Feb; 158(1):7-8. PMID: 16602477.
      Citations:    Fields:    Translation:Humans
    222. Patel AJ, Fuller GN, Wildrick DM, Sawaya R. Pineal cyst apoplexy: case report and review of the literature. Neurosurgery. 2005 Nov; 57(5):E1066; discussion E1066. PMID: 16284546.
      Citations: 10     Fields:    Translation:Humans
    223. McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer. 2005 Oct 01; 104(7):1468-77. PMID: 16088966.
      Citations: 38     Fields:    Translation:HumansCells
    224. McDonald JM, Dunmire V, Taylor E, Sawaya R, Bruner J, Fuller GN, Aldape K, Zhang W. Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss. Mol Cancer. 2005 Sep 12; 4:35. PMID: 16156899; PMCID: PMC1242250.
      Citations: 6     Fields:    Translation:HumansCells
    225. Fuller GN, Mircean C, Tabus I, Taylor E, Sawaya R, Bruner JM, Shmulevich I, Zhang W. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression. Oncol Rep. 2005 Sep; 14(3):651-6. PMID: 16077969.
      Citations: 3     Fields:    
    226. Chen LL, Sabripour M, Wu EF, Prieto VG, Fuller GN, Frazier ML. A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors. Oncogene. 2005 Jun 16; 24(26):4271-80. PMID: 15824741.
      Citations: 16     Fields:    Translation:HumansCells
    227. Neto AG, Fuller GN, Luna MA, Spencer ML. Intracranial extension of acinic cell carcinoma of the parotid gland. Arch Pathol Lab Med. 2005 Jun; 129(6):780-2. PMID: 15913428.
      Citations: 2     Fields:    Translation:HumansCells
    228. Song SW, Fuller GN, Zheng H, Zhang W. Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas. Cancer Res. 2005 May 01; 65(9):3562-7. PMID: 15867349.
      Citations: 11     Fields:    Translation:HumansCells
    229. Dai C, Lyustikman Y, Shih A, Hu X, Fuller GN, Rosenblum M, Holland EC. The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats. Neoplasia. 2005 Apr; 7(4):397-406. PMID: 15967117; PMCID: PMC1501153.
      Citations: 20     Fields:    Translation:AnimalsCells
    230. Kim JH, Tuziak T, Hu L, Wang Z, Bondaruk J, Kim M, Fuller G, Dinney C, Grossman HB, Baggerly K, Zhang W, Czerniak B. Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. Lab Invest. 2005 Apr; 85(4):532-49. PMID: 15778693.
      Citations: 19     Fields:    Translation:HumansCells
    231. Fuller GN, Su X, Price RE, Cohen ZR, Lang FF, Sawaya R, Majumder S. Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16. Mol Cancer Ther. 2005 Mar; 4(3):343-9. PMID: 15767543.
      Citations: 46     Fields:    Translation:HumansAnimalsCells
    232. de Groot JF, Liu TJ, Fuller G, Yung WK. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res. 2005 Mar 01; 65(5):1934-40. PMID: 15753393.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    233. Neto AG, McCutcheon IE, Vang R, Spencer ML, Zhang W, Fuller GN. Elevated expression of p21 (WAF1/Cip1) in hormonally active pituitary adenomas. Ann Diagn Pathol. 2005 Feb; 9(1):6-10. PMID: 15692944.
      Citations: 8     Fields:    Translation:Humans
    234. Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin Cancer Res. 2005 Jan 01; 11(1):267-72. PMID: 15671555.
      Citations: 26     Fields:    Translation:HumansCells
    235. Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GN. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol. 2004 Nov; 28(11):1532-6. PMID: 15489659.
      Citations: 42     Fields:    Translation:HumansCells
    236. Saadati H, Calvano C, Diba R, Fuller GN, Gombos D, De Monte F, Urso R, Esmaeli B. Orbital and optic chiasmal extension of uveal melanoma. Ophthalmic Plast Reconstr Surg. 2004 Sep; 20(5):387-90. PMID: 15377909.
      Citations: 1     Fields:    Translation:Humans
    237. Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res. 2004 Sep 01; 64(17):5913-9. PMID: 15342366.
      Citations: 98     Fields:    Translation:HumansCells
    238. Wang H, Wang H, Zhang W, Huang HJ, Liao WS, Fuller GN. Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest. 2004 Aug; 84(8):941-51. PMID: 15184909.
      Citations: 108     Fields:    Translation:HumansCells
    239. McCutcheon IE, Neto AG, Gupta D, Kumar AJ, Biddle DA, Langford LA, Bruner JM, Leeds NE, Fuller GN, Ribalta T. Textiloma (gossypiboma) mimicking recurrent intracranial tumor. Arch Pathol Lab Med. 2004 Jul; 128(7):749-58. PMID: 15214828.
      Citations: 38     Fields:    Translation:HumansPHPublic Health
    240. Lassman AB, Dai C, Fuller GN, Vickers AJ, Holland EC. Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. Neuron Glia Biol. 2004 May; 1(2):157-63. PMID: 17047730; PMCID: PMC1615889.
      Citations: 24     Fields:    
    241. Hao X, Sun B, Hu L, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, Zhang W, L?hdesm?ki H. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004 Mar 15; 100(6):1110-22. PMID: 15022276.
      Citations: 85     Fields:    Translation:Humans
    242. Raza SM, Fuller GN, Rhee CH, Huang S, Hess K, Zhang W, Sawaya R. Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):212-21. PMID: 14734472.
      Citations: 28     Fields:    Translation:Humans
    243. McCutcheon IE, Hentschel SJ, Fuller GN, Jin W, Cote GJ. Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain. Neuro Oncol. 2004 Jan; 6(1):9-14. PMID: 14769134; PMCID: PMC1871971.
      Citations: 29     Fields:    Translation:HumansCells
    244. Maldaun MV, Suki D, Lang FF, Prabhu S, Shi W, Fuller GN, Wildrick DM, Sawaya R. Cystic glioblastoma multiforme: survival outcomes in 22 cases. J Neurosurg. 2004 Jan; 100(1):61-7. PMID: 14743913.
      Citations: 29     Fields:    Translation:Humans
    245. Vogel H, Fuller GN. Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems. Ann Diagn Pathol. 2003 Dec; 7(6):387-98. PMID: 15018124.
      Citations: 11     Fields:    Translation:Humans
    246. Song SW, Fuller GN, Khan A, Kong S, Shen W, Taylor E, Ramdas L, Lang FF, Zhang W. IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):13970-5. PMID: 14617774; PMCID: PMC283530.
      Citations: 36     Fields:    Translation:HumansAnimalsCells
    247. Wang H, Shen SS, Wang H, Diwan AH, Zhang W, Fuller GN, Prieto VG. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. J Cutan Pathol. 2003 Nov; 30(10):599-605. PMID: 14744083.
      Citations: 11     Fields:    Translation:HumansCells
    248. Han XY, Weinberg JS, Prabhu SS, Hassenbusch SJ, Fuller GN, Tarrand JJ, Kontoyiannis DP. Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. J Neurosurg. 2003 Oct; 99(4):693-700. PMID: 14567605.
      Citations: 24     Fields:    Translation:HumansCells
    249. Baumgartner JE, Ater JL, Ha CS, Kuttesch JF, Leeds NE, Fuller GN, Wilson RJ. Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors. Pediatr Neurosurg. 2003 Oct; 39(4):201-7. PMID: 12944701.
      Citations: 20     Fields:    Translation:Humans
    250. Hong DS, Jacobson KL, Raad II, de Lima M, Anderlini P, Fuller GN, Ippoliti C, Cool RM, Leeds NE, Narvios A, Han XY, Padula A, Champlin RE, Hosing C. West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review. Clin Infect Dis. 2003 Oct 15; 37(8):1044-9. PMID: 14523768.
      Citations: 3     Fields:    Translation:HumansCells
    251. Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, Zhang W. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003 Aug 01; 63(15):4315-21. PMID: 12907597.
      Citations: 88     Fields:    Translation:HumansCells
    252. Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MH. Gliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Jul 15; 56(4):1137-46. PMID: 12829152.
      Citations: 16     Fields:    Translation:Humans
    253. Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol. 2003 Jul 01; 21(13):2508-18. PMID: 12839017.
      Citations: 139     Fields:    Translation:HumansCellsCTClinical Trials
    254. Lee HK, Chang EL, Fuller GN, Aldape KD, Atkinson GJ, Levy LB, McCutcheon IE, Maor MH. The prognostic value of neurologic function in astrocytic spinal cord glioma. Neuro Oncol. 2003 07; 5(3):208-13. PMID: 12816727; PMCID: PMC1920688.
      Citations: 9     Fields:    Translation:Humans
    255. Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, Sawaya R, Curiel DT, Yung WK, Lang FF. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst. 2003 May 07; 95(9):652-60. PMID: 12734316.
      Citations: 143     Fields:    Translation:HumansAnimalsCells
    256. Brown HM, McCutcheon IE, Leeds NE, Schomer DS, Luna MA, Fuller GN. Melanoma metastatic to central neurocytoma: a novel case of tumor-to-tumor metastasis. J Neurooncol. 2003 Feb; 61(3):209-14. PMID: 12675313.
      Citations: 3     Fields:    Translation:Humans
    257. Tran TA, Fuller GN, Whitman GJ, Schomer DF. Radiologic-pathologic conferences of the University of Texas M.D. Anderson Cancer Center. Delayed cerebral radiation necrosis. AJR Am J Roentgenol. 2003 Jan; 180(1):70. PMID: 12490478.
      Citations:    Fields:    Translation:HumansPHPublic Health
    258. Fuller CE, Wang H, Zhang W, Fuller GN, Perry A. High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). J Neuropathol Exp Neurol. 2002 Dec; 61(12):1078-84. PMID: 12484570.
      Citations: 12     Fields:    Translation:HumansCells
    259. Shukla V, Hayman LA, Ly C, Fuller G, Taber KH. Adult cranial dura I: intrinsic vessels. J Comput Assist Tomogr. 2002 Nov-Dec; 26(6):1069-74. PMID: 12488763.
      Citations: 4     Fields:    Translation:Humans
    260. Kim S, Dougherty ER, Shmulevich I, Hess KR, Hamilton SR, Trent JM, Fuller GN, Zhang W. Identification of combination gene sets for glioma classification. Mol Cancer Ther. 2002 Nov; 1(13):1229-36. PMID: 12479704.
      Citations: 36     Fields:    Translation:Humans
    261. Lang FF, Gilbert MR, Puduvalli VK, Weinberg J, Levin VA, Yung WK, Sawaya R, Fuller GN, Conrad CA. Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies. Neuro Oncol. 2002 10; 4(4):268-77. PMID: 12356357; PMCID: PMC1920662.
      Citations: 24     Fields:    Translation:Humans
    262. Raza SM, Lang FF, Aggarwal BB, Fuller GN, Wildrick DM, Sawaya R. Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery. 2002 Jul; 51(1):2-12; discussion 12-3. PMID: 12182418.
      Citations: 65     Fields:    Translation:HumansCells
    263. Tremont-Lukats IW, Fuller GN, Ribalta T, Giglio P, Groves MD. Paraneoplastic chorea: case study with autopsy confirmation. Neuro Oncol. 2002 07; 4(3):192-5. PMID: 12084350; PMCID: PMC1920638.
      Citations: 2     Fields:    Translation:HumansCells
    264. Hu L, Wang J, Baggerly K, Wang H, Fuller GN, Hamilton SR, Coombes KR, Zhang W. Obtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics. 2002 Jun 21; 3:16. PMID: 12086591; PMCID: PMC117130.
      Citations: 27     Fields:    
    265. Marmor E, Fourney DR, Rhines LD, Skibber JM, Fuller GN, Gokaslan ZL. Sacrococcygeal ganglioneuroma. J Spinal Disord Tech. 2002 Jun; 15(3):265-8. PMID: 12131432.
      Citations: 6     Fields:    Translation:Humans
    266. Cohen ZR, Marmor E, Fuller GN, DeMonte F. Misdiagnosis of olfactory neuroblastoma. Neurosurg Focus. 2002 May 15; 12(5):e3. PMID: 16119901.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    267. Adachi Y, Chandrasekar N, Kin Y, Lakka SS, Mohanam S, Yanamandra N, Mohan PM, Fuller GN, Fang B, Fueyo J, Dinh DH, Olivero WC, Tamiya T, Ohmoto T, Kyritsis AP, Rao JS. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene. 2002 Jan 03; 21(1):87-95. PMID: 11791179.
      Citations: 9     Fields:    Translation:HumansCells
    268. Zhang W, Wang H, Song SW, Fuller GN. Insulin-like growth factor binding protein 2: gene expression microarrays and the hypothesis-generation paradigm. Brain Pathol. 2002 Jan; 12(1):87-94. PMID: 11770904; PMCID: PMC8095777.
      Citations: 11     Fields:    Translation:Humans
    269. Fuller GN, Hess KR, Rhee CH, Yung WK, Sawaya RA, Bruner JM, Zhang W. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets. Brain Pathol. 2002 Jan; 12(1):108-16. PMID: 11771519; PMCID: PMC8096049.
      Citations: 25     Fields:    Translation:Humans
    270. Begemann M, Fuller GN, Holland EC. Genetic modeling of glioma formation in mice. Brain Pathol. 2002 Jan; 12(1):117-32. PMID: 11770894; PMCID: PMC8095879.
      Citations: 8     Fields:    Translation:AnimalsCells
    271. Wang H, Wang H, Zhang W, Fuller GN. Tissue microarrays: applications in neuropathology research, diagnosis, and education. Brain Pathol. 2002 Jan; 12(1):95-107. PMID: 11770905; PMCID: PMC8095954.
      Citations: 47     Fields:    Translation:HumansAnimals
    272. Verma KK, Forman AD, Fuller GN, Dimachkie MM, Vriesendorp FJ. Cauda equina syndrome as the isolated presentation of sarcoidosis. J Neurol. 2000 Jul; 247(7):573-4. PMID: 10993507.
      Citations: 3     Fields:    Translation:Humans
    273. Lueder GT. Successful therapy for trilateral retinoblastoma. Am J Ophthalmol. 1992 Nov 15; 114(5):646-7. PMID: 1443038.
      Citations: 1     Fields:    Translation:Humans
    274. Abramson DH. Successful therapy for trilateral retinoblastoma. Am J Ophthalmol. 1992 Nov 15; 114(5):647-8. PMID: 1443039.
      Citations:    Fields:    Translation:Humans
    275. Fuller GN, Rigor BM, Wiggins RC, Dafny N. Prolonged daily inhalation of halothane modifies the dose-response pattern to acute administration of halothane. An electrophysiological study. Neuropharmacology. 1985 Nov; 24(11):1033-8. PMID: 4080102.
      Citations:    Fields:    Translation:Animals
    276. Wiggins RC, Fuller G, Enna SJ. Undernutrition and the development of brain neurotransmitter systems. Life Sci. 1984 Nov 19; 35(21):2085-94. PMID: 6149444.
      Citations: 18     Fields:    Translation:Animals
    277. Wiggins RC, Fuller GN, Brizzee L, Bissel AC, Samorajski T. Myelination of the rat optic nerve during postnatal undernourishment and recovery: a morphometric analysis. Brain Res. 1984 Aug 13; 308(2):263-72. PMID: 6478208.
      Citations: 6     Fields:    Translation:AnimalsCells
    278. Fuller GN, Wiggins RC. Differential growth recovery within the brains of postnatally undernourished rats. Brain Res. 1984 Aug; 317(2):280-2. PMID: 6478252.
      Citations: 1     Fields:    Translation:Animals
    279. Fuller GN, Johnston DA, Wiggins RC. The relationship between nutritional adequacy and brain myelin accumulation: a comparison of varying degrees of well fed and undernourished rats. Brain Res. 1984 Jan 02; 290(1):195-8. PMID: 6419986.
      Citations: 5     Fields:    Translation:AnimalsCells
    280. Fuller GN, Divakaran P, Wiggins RC. The effect of postnatal caffeine administration on brain myelination. Brain Res. 1982 Oct 07; 249(1):189-91. PMID: 7139294.
      Citations: 4     Fields:    Translation:AnimalsCells
    281. Wiggins RC, Fuller GN, Dafny N. Propagation of photic evoked responses recorded from the retina, optic chiasm, lateral geniculate body, and visual cortex of the nutritionally rehabilitated rat visual system. Exp Neurol. 1982 Sep; 77(3):644-53. PMID: 7117468.
      Citations: 3     Fields:    Translation:Animals
    282. Wiggins RC, Fuller GN. Analysis of distribution of rat sciatic nerve protein among soluble, insoluble, and myelin subfraction. Neurochem Res. 1981 Jun; 6(6):719-27. PMID: 7279118.
      Citations: 4     Fields:    Translation:Animals
    283. Gottesfeld Z, Fuller GN, Wiggins RC. Adrenergic neuroplasticity is maintained in the nutritional rehabilitated adult rat. Experientia. 1981 Feb 15; 37(2):168-9. PMID: 7238746.
      Citations:    Fields:    Translation:AnimalsCells
    284. Wiggins RC, Fuller GN, Dafny N. The electroretinogram of adult rats following a period of postnatal undernutrition and prolonged nutritional rehabilitation. Life Sci. 1980 Apr 07; 26(14):1169-74. PMID: 7392794.
      Citations:    Fields:    Translation:Animals
    285. Wiggins RC, Fuller GN, Astrello JM, Rigor BM. Decreased myelin synthesis in developing rats following repeated pre- and perinatal exposure to subanesthetic amounts of halothane. J Neurochem. 1979 Jul; 33(1):361-3. PMID: 458464.
      Citations: 2     Fields:    Translation:AnimalsCells
    286. Wiggins RC, Fuller GN, Bell ME. Incorporation of leucine metabolites into brain and sciatic nerve myelin. J Neurochem. 1979 May; 32(5):1579-82. PMID: 438825.
      Citations: 3     Fields:    Translation:Animals
    287. Comparison of the invasiveness profiles of en plaque and globoid meningiomas. Skull Base Surgery. 9:7.
    288. Introduction. Brain Pathology. 12:53.
    289. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum. American Journal of Surgical Pathology.
    290. Finding functional structures in glioma gene-expressions using gene shaving clustering and MDL principle. 89-118.
    291. Central nervous system.
    292. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 167:1281-1295.e18.
    293. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathologica. 130:587-597.
    294. Progressive diffuse meningioangiomatosis. Neurology. 86:1643-1644.
    295. Obtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics. 3.
    296. Brain Metastases. 55-70.
    297. Whole-transcriptome analysis of chordoma of the skull base. Virchows Archiv. 1-11.
    298. Tumor-associated methylation of the putative tumor suppressor ajap1 gene and association between decreased ajap1 expression and shorter survival in patients with glioma. Chinese Journal of Cancer. 30:254-263.
    299. IGFBP2 potentiates nuclear EGFR-STAT3 signaling. Oncogene. 35:738-747.
    300. PD-L1 expression and prognostic impact in glioblastoma. Neuro-Oncology. 18:195-205.
    301. Erratum to. Journal of Neuro-Oncology. 119:37.
    302. Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma. Oncotarget. 7:26793-26805.
    303. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro-Oncology. 18:639-648.
    304. miR-182-5p induced by STAT3 activation promotes glioma tumorigenesis. Cancer Research. 76:4293-4304.
    305. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation. Nature Genetics. 49:75-86.
    306. REST regulates oncogenic properties of glioblastoma stem cells (Stem Cells (2012) 30 (405-414) DOI. Stem Cells. 30:1049.
    307. Sarcoma Brain Metastases. Annals of Surgical Oncology. 1-6.
    308. The 2007 WHO classification of tumors of the nervous system. Brain Pathology. 18:640.
    309. Epithelial, Neuroendocrine, and Metastatic Lesions. 287-313.
    310. Differential growth recovery within the brains of postnatally undernourished rats. Developmental Brain Research. 15:280-282.
    311. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. Journal of Neuro-Oncology. 1-8.
    312. Molecular diagnosis of glioma. 520-527.
    313. Gliomatosis peritonei. Modern Pathology. 1613-1620.
    314. Immune checkpoint blockade as a potential therapeutic target. Neuro-Oncology. 18:1357-1366.
    315. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis. Oncotarget. 7:23521-23529.
    316. Intraoperative Consultation and Optimal Processing. 35-45.
    317. Brain tumors. Archives of Pathology and Laboratory Medicine. 131:225-227.
    318. Dorsal column myelopathy after intrathecal chemotherapy for leukemia. American Journal of Hematology. 92:155-160.
    319. Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. OncoImmunology.
    320. The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation. Oncogene.
    321. PINK1 is a negative regulator of growth and the warburg effect in glioblastoma. Cancer Research. 76:4708-4719.
    322. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutation Research - Reviews in Mutation Research. 276:299-306.
    323. Mitotic index is an independent predictor of recurrence-free survival in meningioma. Brain Pathology. 25:266-275.
    324. Mir-21-Sox2 axis delineates glioblastoma subtypes with prognostic impact. Journal of Neuroscience. 35:15097-15112.
    FULLER's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (936)
    Explore
    _
    Co-Authors (247)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _